Evaluation and Treatment of Pericarditis: A Systematic Review.

Pericarditis is the most common form of pericardial disease and a relatively common cause of chest pain.
To summarize published evidence on the causes, diagnosis, therapy, prevention, and prognosis of pericarditis.
A literature search of BioMedCentral, Google Scholar, MEDLINE, Scopus, and the Cochrane Database of Systematic Reviews was performed for human studies without language restriction from January 1, 1990, to August 31, 2015. After literature review and selection of meta-analyses, randomized clinical trials, and large observational studies, 30 studies (5 meta-analyses, 10 randomized clinical trials, and 16 cohort studies) with 7569 adult patients were selected for inclusion.
The etiology of pericarditis may be infectious (eg, viral and bacterial) or noninfectious (eg, systemic inflammatory diseases, cancer, and post-cardiac injury syndromes). Tuberculosis is a major cause of pericarditis in developing countries but accounts for less than 5% of cases in developed countries, where idiopathic, presumed viral causes are responsible for 80% to 90% of cases. The diagnosis is based on clinical criteria including chest pain, a pericardial rub, electrocardiographic changes, and pericardial effusion. Certain features at presentation (temperature >38°C [>100.4°F], subacute course, large effusion or tamponade, and failure of nonsteroidal anti-inflammatory drug [NSAID] treatment) indicate a poorer prognosis and identify patients requiring hospital admission. The most common treatment for idiopathic and viral pericarditis in North America and Europe is NSAID therapy. Adjunctive colchicine can ameliorate the initial episode and is associated with approximately 50% lower recurrence rates. Corticosteroids are a second-line therapy for those who do not respond, are intolerant, or have contraindications to NSAIDs and colchicine. Recurrences may occur in 30% of patients without preventive therapy.
Pericarditis is the most common form of pericardial disease worldwide and may recur in as many as one-third of patients who present with idiopathic or viral pericarditis. Appropriate triage and treatment with NSAIDs may reduce readmission rates for pericarditis. Treatment with colchicine can reduce recurrence rates.
AuthorsMassimo Imazio, Fiorenzo Gaita, Martin LeWinter
JournalJAMA (JAMA) Vol. 314 Issue 14 Pg. 1498-506 (Oct 13 2015) ISSN: 1538-3598 [Electronic] United States
PMID26461998 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Colchicine
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Chest Pain (etiology)
  • Cohort Studies
  • Colchicine (therapeutic use)
  • Humans
  • Meta-Analysis as Topic
  • Pericardial Effusion (diagnosis, etiology)
  • Pericarditis (diagnosis, drug therapy, etiology, mortality, prevention & control)
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Symptom Assessment (methods)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: